Floatz logo

Docetaxel

BCT Rate

Shanghai Jiao Tong University School of MedicineSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the BCT Rate cohort.

Asset / SponsorPhaseRating
Epirubicin
Shanghai Jiao Tong University School of Medicine
Phase 2CCC
Metformin
Shanghai Jiao Tong University School of Medicine
Phase 2CCC
Letrozole
Shanghai Jiao Tong University School of Medicine
Phase 2CCC
Cyclophosphamide
Shanghai Jiao Tong University School of Medicine
Phase 2CCC

Same molecule, other indications

Docetaxel is also rated in:

prostate neoplasmDormant
BBB
Indicative ·
73 / 100
View asset →
pancreatic adenocarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →